Implicity is a Paris- and Cambridge, MA-based digital MedTech company founded in 2016 by cardiac electrophysiologist Dr. Arnaud Rosier. Its manufacturer-agnostic SaaS platform aggregates, normalizes and analyzes data from cardiac implantable electronic devices across all major manufacturers, applying CE- and FDA-cleared AI algorithms — including SignalHF, the first FDA-cleared, manufacturer-agnostic heart-failure prediction algorithm — to cut alert fatigue and flag rising heart-failure risk for care teams. The platform is used daily at more than 250 medical centers monitoring over 120,000 patients across the US and Europe, and the company EVIDENCE-RM real-world study reported a 26% reduction in all-cause mortality.
1
Round
1
Industry
5
Tags
Sep 9, 2026
Latest raise
Funding activity · 1 round
Sep 9, 2026
EUR 35M
Series C+
Led by IRIS
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
